Sullivan, Bruyette, Speros & Blaney’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $905K | Buy |
14,333
+2,938
| +26% | +$186K | 0.04% | 124 |
|
|
2020
Q4 | $707K | Sell |
11,395
-355
| -3% | -$22K | 0.03% | 137 |
|
|
2020
Q3 | $708K | Buy |
11,750
+4
| +0% | +$241 | 0.04% | 121 |
|
|
2020
Q2 | $691K | Sell |
11,746
-643
| -5% | -$37.8K | 0.04% | 113 |
|
|
2020
Q1 | $691K | Sell |
12,389
-98
| -0.8% | -$5.47K | 0.05% | 104 |
|
|
2019
Q4 | $802K | Buy |
12,487
+1,402
| +13% | +$90K | 0.04% | 106 |
|
|
2019
Q3 | $562K | Sell |
11,085
-272
| -2% | -$13.8K | 0.03% | 122 |
|
|
2019
Q2 | $515K | Buy |
11,357
+405
| +4% | +$18.4K | 0.03% | 125 |
|
|
2019
Q1 | $523K | Sell |
10,952
-271
| -2% | -$12.9K | 0.03% | 119 |
|
|
2018
Q4 | $583K | Buy |
11,223
+9
| +0.1% | +$468 | 0.04% | 98 |
|
|
2018
Q3 | $696K | Sell |
11,214
-1,773
| -14% | -$110K | 0.06% | 75 |
|
|
2018
Q2 | $719K | Buy |
12,987
+12
| +0.1% | +$664 | 0.07% | 70 |
|
|
2018
Q1 | $821K | Buy |
12,975
+10
| +0.1% | +$633 | 0.08% | 64 |
|
|
2017
Q4 | $795K | Sell |
12,965
-5,986
| -32% | -$367K | 0.08% | 69 |
|
|
2017
Q3 | $1.21M | Sell |
18,951
-767
| -4% | -$48.9K | 0.12% | 47 |
|
|
2017
Q2 | $1.1M | Buy |
19,718
+697
| +4% | +$38.8K | 0.11% | 50 |
|
|
2017
Q1 | $1.03M | Buy |
19,021
+1
| +0% | +$54 | 0.1% | 46 |
|
|
2016
Q4 | $1.11M | Hold |
19,020
| – | – | 0.11% | 41 |
|
|
2016
Q3 | $1.03M | Buy |
19,020
+2,981
| +19% | +$161K | 0.1% | 45 |
|
|
2016
Q2 | $1.18M | Buy |
+16,039
| New | +$1.18M | 0.12% | 39 |
|